Immediate antipyretic effect of Hufu Copper Guasha on sepsis patients with exogenous fever: a randomized controlled trial
- Conditions
- sepsis
- Registration Number
- ITMCTR2000003287
- Lead Sponsor
- Guangdong Provincial Hospital of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. aged between 18 and 70 years;
2. patients consistent with the diagnosis of sepsis and exogenous fever;
3. axillary temperature between 38.0 and 40.0 degrees C;
4. hyperthermia within 2 days;
5. sequential organ failure assessment (SOFA) <= 3 points;
6. patients sign the informed consent form voluntarily.
1. pregnant and lactating women;
2. patients with central nervous fever;
3. patients with diabetes, malignancy or mental illness;
4. patients with coagulopathy;
5. patients with scar constitution and positive skin scratch test;
6. patients with A and B acute infectious diseases;
7. patients who have used other antipyretic drugs;
8. those with skin rashes, breakages, blisters, or ulcers on the surface of the Guasha area;
9. fever with convulsions, seizures, and closure.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method body temperature (axillary temperature);
- Secondary Outcome Measures
Name Time Method Interleukin 6 (IL-6);procalcitonin (PCT);tumor necrosis factor–a (TNF-a);C-reactive protein (CPR);white blood cell (WBC);